• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Clorox Company filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    1/22/26 4:11:47 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary
    Get the next $CLX alert in real time by email
    false 0000021076 0000021076 2026-01-17 2026-01-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT
    Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): January 17, 2026

     

     

    THE CLOROX COMPANY
    (Exact name of registrant as specified in its charter)

     

     

    Delaware 1-07151 31-0595760
    (State or other jurisdiction of (Commission File Number) (I.R.S. Employer
    incorporation)   Identification No.)

    1221 Broadway, Oakland, California 94612-1888
    (Address of principal executive offices) (Zip code)

     

    (510) 271-7000
    (Registrant's telephone number, including area code)

     

    Not applicable
    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)
       
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class Trading
    Symbol(s)
    Name of each exchange on which registered
    Common Stock - $1.00 par value CLX New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

     

    Emerging growth company     ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     1

     

    Item 7.01 Regulation FD Disclosure

    In connection with the entry into the membership interest purchase agreement as described in Item 8.01 below, Clorox posted to its investor relations section of its website an investor presentation relating to its purchase of the membership interest of GOJO Industries, Inc. (“GOJO”) and issued a press release that reaffirms Clorox’s fiscal year 2026 outlook for net sales, diluted EPS and adjusted EPS. The full text of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. 

    Item 8.01 Other Events

    On January 22, 2026, Clorox announced that it had entered into a membership interest purchase agreement, by and among Clorox, GOJO Industries Holdings, Inc. (“Parent”), GOJO and the shareholders of Parent, pursuant to which Clorox has agreed to purchase all of the issued and outstanding membership interests of GOJO, maker of PURELL®, at a purchase price of $2.25 billion in cash, subject to customary adjustments and including anticipated tax benefits valued at approximately $330 million. Clorox plans to fund the transaction primarily through debt financing. The transaction is subject to regulatory approval and other customary closing conditions.

    Item 9.01 Financial Statements and Exhibits

    (d) Exhibits

    See the Exhibit Index below.

    EXHIBIT INDEX

    Exhibit Description
    99.1 Press Release dated January 22, 2026 of The Clorox Company
    104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

     

    Forward-Looking Statements 

     

    This Current Report on Form 8-K, and the press release incorporated by reference into Item 7.01 of this Current Report on Form 8-K, contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, among others, statements related to our fiscal 2026 full year outlook, the planned acquisition of GOJO and the timing thereof, the ability to obtain regulatory approval and meet other closing conditions for the planned acquisition, the expected impact of the planned acquisition on the company’s net sales, earnings performance, profitability, cash flow, leverage and other financial measures, expectations regarding growth potential in various products, geographies and market categories, including the impact from a more diversified portfolio of brands and business mix, the realization of anticipated synergies, margin expansion and adjusted earnings per share accretion from the acquisition, the terms, timing and scope of the expected financing in connection with the acquisition, the aggregate amount of indebtedness of the company following the closing of the acquisition, and the ability to retain key personnel, and any such forward-looking statements involve risks, assumptions and uncertainties. Except for historical information, statements about future volumes, sales, organic sales growth, foreign currencies, costs, cost savings, margins, earnings, earnings per share, including as a result of the GOJO acquisition, diluted earnings per share, foreign currency exchange rates, tax rates, cash flows, plans, objectives, expectations, growth or profitability are forward-looking statements based on management's estimates, beliefs, assumptions and projections. Words such as "could," "may," "expects," "anticipates," "targets," "goals," "projects," "intends," "plans," "believes," "seeks," "estimates," "will," "predicts," and variations on such words, and similar expressions that reflect our current views with respect to future events and operational, economic and financial performance are intended to identify such forward-looking statements. These forward-looking statements are only predictions, subject to risks and uncertainties, and actual results could differ materially from those discussed. Important factors that could affect performance and cause results to differ materially from management's expectations, are described in the sections entitled "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the company's Annual Report on Form 10-K for the fiscal year ended June 30, 2025, as updated from time to time in the company's Securities and Exchange Commission filings. These factors include, but are not limited to: occurrence of any event, change or other circumstance that could give rise to the termination of the GOJO acquisition agreement; the risk that the conditions to the completion of the proposed acquisition (including regulatory approval) are not satisfied in a timely manner or at all; the risks arising from the integration of the GOJO business; the uncertainty of rating agency actions; the risk that the anticipated benefits and synergies of the proposed acquisition may not be realized when expected or at all; the risk that the proposed acquisition may not be completed in a timely manner or at all; the risk of unexpected

     

     2

     

    costs or expenses resulting from the proposed acquisition; the risk of litigation related to the proposed acquisition, including resulting expense or delay; the risks related to disruption to ongoing business operations of the company and GOJO and diversion of time of management of the company and GOJO as a result of the proposed acquisition; the risk that the proposed acquisition may have an adverse effect on the ability of the company and GOJO to retain key personnel, customers and suppliers; the risk that the credit ratings of the company decline following the proposed acquisition; the risk that the announcement or the consummation of the proposed acquisition has a negative effect on the market price of the common stock of the company or on the company’s or GOJO’s operating results; unfavorable general economic and geopolitical conditions beyond our control, including inflation, supply chain disruptions, labor shortages, wage pressures, fuel and energy costs, interest rate fluctuations, foreign currency exchange rate fluctuations, weather events or natural disasters, disease outbreaks or pandemics, terrorism, and unstable geopolitical conditions, including ongoing conflicts and rising tensions in the Middle East and/or Ukraine and rising tensions between China and Taiwan, as well as macroeconomic and geopolitical volatility and uncertainty as a result of a number of these and other factors, including actual and potential shifts in U.S. and foreign trade policies, including as a result of escalating trade tensions between the U.S. and its trading partners, especially China, particularly as a result of the imposition of U.S. and retaliatory tariffs; the impact of market and category declines, and the company’s product and geographic mix on its ability to meet sales growth targets; the company’s ability to successfully execute or realize the anticipated benefits of its strategic or transformational initiatives, including the ERP transition and the related timing and volume of shipment movement related to the ERP transition; the impact of the changing retail environment, including the growth of alternative retail channels and business models, and changing consumer preferences; intense competition in the company's markets; volatility and increases in the costs of raw materials, energy, transportation, labor and other necessary supplies or services; risks related to supply chain issues, product shortages and disruptions to the business, as a result of increased supply chain dependencies due to an expanded supplier network and a reliance on certain single-source suppliers; risks related to the company's use of and reliance on information technology systems, including potential and actual security breaches, cyberattacks, privacy breaches or data breaches that result in the unauthorized disclosure of consumer, customer, employee or company information, business, service or operational disruptions, or that impact the company's financial results or financial reporting, or any resulting unfavorable outcomes, increased costs or legal proceedings; the ability of the company to innovate and to develop and introduce commercially successful products, or expand into adjacent categories and countries; the ability of the company to successfully manage global political, legal, tax and regulatory risks, including due to regulatory uncertainty and lack of regulatory convergence among different jurisdictions; lower revenue, increased costs, other financial statement impacts or reputational harm resulting from government actions, compliance with regulations, or any material costs imposed by changes in regulation; the company's ability to maintain its business reputation and the reputation of its brands and products; dependence on key customers and risks related to customer consolidation and ordering patterns; the company's ability to attract and retain key personnel, which may continue to be impacted by challenges in the labor market, such as increasing labor costs and sustained labor shortages; changes to our processes and procedures as a result of our digital capabilities and productivity enhancements that may result in changes to the company's internal controls over financial reporting; risks related to the acquisition of The Procter & Gamble Company’s interest in the Glad business; risks related to international operations and international trade, including changing macroeconomic conditions as a result of inflation, volatile commodity prices and increases in raw and packaging materials prices, labor, energy and logistics; global economic or political instability; foreign currency fluctuations, such as devaluations, and foreign currency exchange rate controls; changes in governmental policies, including trade policy and tariffs, travel or immigration restrictions, new or additional tariffs, and price or other controls; labor claims and civil unrest; potential operational or supply chain disruptions from wars and military conflicts, including ongoing conflicts and rising tensions in the Middle East and/or Ukraine and rising tensions between China and Taiwan; potential negative impact and liabilities from the use, storage and transportation of chlorine in certain international markets where chlorine is used in the production of bleach; widespread health emergencies; and the possibility of nationalization, expropriation of assets or other government action or inaction, including the impacts of a prolonged U.S. government shutdown; the impact of climate change and other sustainability issues on sales, operating costs, reputation or stakeholder relationships; the impact of product liability claims, labor claims and other legal, governmental or tax proceedings, including in foreign jurisdictions and in connection with any product recalls; risks relating to acquisitions, new ventures and divestitures, and associated costs, including for asset impairment charges related to, among others, intangible assets, including trademarks and goodwill; and the ability to complete announced transactions, including the acquisition of GOJO, and, if completed, integration costs and potential contingent liabilities related to those transactions; the accuracy of the company's estimates and assumptions on which its financial projections, including any sales or earnings guidance or outlook it may provide from time to time, are based; risks related to our reliance on third-party service providers, including inability to meet cost savings or efficiencies, business or systems disruptions, and other liabilities, including legal or regulatory risk; environmental matters, including costs associated with the remediation and monitoring of past contamination, and possible increases in costs resulting from actions by relevant regulators, and the handling and/or transportation of hazardous substances; the company's ability to effectively utilize, assert and defend its intellectual property rights, and any infringement or claimed infringement by the company of third-party intellectual property rights; the effect of the company's indebtedness and credit rating on its business operations and financial results and the company's ability to access capital markets and other funding sources, as well as the cost of capital to the company; the company's ability to pay and declare dividends or repurchase its stock in the future; and the impacts of potential stockholder activism.  

     

    The company's forward-looking statements in this Current Report on Form 8-K, and the press release incorporated by reference into Item 7.01 of this Current Report on Form 8-K, are based on management's current views, beliefs, assumptions and

     

     3

     

    expectations regarding future events and speak only as of the date of this Current Report on Form 8-K. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the federal securities laws. 

     

     4

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

        THE CLOROX COMPANY

     

    Date: January 22, 2026 By:  /s/ Angela Hilt
          Angela Hilt
         

    Executive Vice President – Chief Legal and External Affairs Officer & Corporate Secretary

     

     5

    Get the next $CLX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CLX

    DatePrice TargetRatingAnalyst
    2/11/2026Underperform → Neutral
    BNP Paribas Exane
    10/1/2025$118.00 → $112.00Underweight
    Barclays
    1/7/2025$157.00Underweight → Equal Weight
    Wells Fargo
    11/6/2024$155.00 → $170.00Sell → Hold
    TD Cowen
    10/1/2024$174.00 → $187.00Hold → Buy
    Jefferies
    7/23/2024$122.00Sell
    TD Cowen
    6/24/2024$130.00Underperform
    Exane BNP Paribas
    4/2/2024$170.00 → $165.00Buy → Neutral
    Citigroup
    More analyst ratings

    $CLX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Williams Christopher J

    4 - CLOROX CO /DE/ (0000021076) (Issuer)

    1/5/26 4:50:10 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    SEC Form 4 filed by Director Weiner Russell J

    4 - CLOROX CO /DE/ (0000021076) (Issuer)

    1/5/26 4:49:10 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    SEC Form 4 filed by Director Plaines Stephanie

    4 - CLOROX CO /DE/ (0000021076) (Issuer)

    1/5/26 4:47:53 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    $CLX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Clorox upgraded by BNP Paribas Exane

    BNP Paribas Exane upgraded Clorox from Underperform to Neutral

    2/11/26 8:53:35 AM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Barclays reiterated coverage on Clorox with a new price target

    Barclays reiterated coverage of Clorox with a rating of Underweight and set a new price target of $112.00 from $118.00 previously

    10/1/25 10:49:28 AM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Clorox upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Clorox from Underweight to Equal Weight and set a new price target of $157.00

    1/7/25 7:46:13 AM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    $CLX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    The Clorox Company Unveils Home Care Redefined: A Look at How Americans Are Reimagining Time, Wellness, and Convenience at Home

    Report underscores the evolution of home care from a string of chores into a meaningful source of accomplishment, satisfaction, and self‑careAwareness of the home's influence on family health is rising, and younger generations are taking a more proactive, wellness‑focused approach to home careConvenience is being reimagined: consumers now value ease and enjoyment over sheer speed in their everyday routinesOAKLAND, Calif., Feb. 19, 2026 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today announced the release of Home Care Redefined, a first-of-its-kind report designed to define the evolving landscape of consumer home care. Drawing on extensive consumer research and insights, the report detail

    2/19/26 9:00:00 AM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Clorox to Present at 2026 CAGNY Conference

    OAKLAND, Calif., Feb. 4, 2026 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today announced that Chair and Chief Executive Officer Linda Rendle and Chief Financial Officer Luc Bellet will be featured speakers at the Consumer Analyst Group of New York's (CAGNY) annual conference in Orlando, Florida, on Thursday, Feb. 19. A live webcast of the presentation will begin at 2:00 p.m. ET (11:00 a.m. PT) and can be accessed on the company's website. A replay of the webcast will be available following the event.About The Clorox Company The Clorox Company (NYSE:CLX) champions people to be well and thrive every single day. Headquartered in Oakland, California since 1913, Clorox integrates sustainabilit

    2/4/26 4:15:00 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Clorox Reports Q2 Fiscal Year 2026 Results, Confirms Outlook

    OAKLAND, Calif., Feb. 3, 2026 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today reported results for the second quarter of fiscal year 2026, which ended December 31, 2025. Second-Quarter Fiscal Year 2026 Summary Following is a summary of key results for the second quarter. All comparisons are with the second quarter of fiscal year 2025 unless otherwise stated. Net sales decreased 1% to $1.67 billion, primarily driven by lower consumption and partially offset by shipments ahead of consumption for several businesses. Organic sales1 decreased 1%.Gross margin decreased 60 basis points to 43.2% from 43.8% in the year-ago quarter, primarily driven by higher manufacturing and logistics costs, par

    2/3/26 4:10:00 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    $CLX
    SEC Filings

    View All

    SEC Form 10-Q filed by Clorox Company

    10-Q - CLOROX CO /DE/ (0000021076) (Filer)

    2/3/26 4:45:17 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Clorox Company filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - CLOROX CO /DE/ (0000021076) (Filer)

    2/3/26 4:11:43 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Clorox Company filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - CLOROX CO /DE/ (0000021076) (Filer)

    1/22/26 4:11:47 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    $CLX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Breber Pierre R bought $416,516 worth of shares (4,000 units at $104.13) (SEC Form 4)

    4 - CLOROX CO /DE/ (0000021076) (Issuer)

    11/24/25 4:37:00 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Director Breber Pierre R bought $546,285 worth of shares (4,000 units at $136.57) (SEC Form 4)

    4 - CLOROX CO /DE/ (0000021076) (Issuer)

    5/9/25 4:25:25 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    $CLX
    Financials

    Live finance-specific insights

    View All

    Clorox Reports Q2 Fiscal Year 2026 Results, Confirms Outlook

    OAKLAND, Calif., Feb. 3, 2026 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today reported results for the second quarter of fiscal year 2026, which ended December 31, 2025. Second-Quarter Fiscal Year 2026 Summary Following is a summary of key results for the second quarter. All comparisons are with the second quarter of fiscal year 2025 unless otherwise stated. Net sales decreased 1% to $1.67 billion, primarily driven by lower consumption and partially offset by shipments ahead of consumption for several businesses. Organic sales1 decreased 1%.Gross margin decreased 60 basis points to 43.2% from 43.8% in the year-ago quarter, primarily driven by higher manufacturing and logistics costs, par

    2/3/26 4:10:00 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Clorox Announces Acquisition of GOJO Industries, Makers of Purell®, Market Leader in Skin Health and Hygiene

    Expands Clorox's position in health and hygiene to include skin hygiene Clorox's scale, innovation and distribution capabilities poised to accelerate consumer growth for the Purell brand while GOJO's B2B reach and capabilities bolster Clorox's professional business Acquisition is growth accretive and advances IGNITE strategy; further evolving Clorox's portfolio to strengthen its ability to deliver more consistent, profitable growth OAKLAND, Calif., Jan. 22, 2026  The Clorox Company (NYSE:CLX) today announced that it has entered into a definitive agreement to acquire GOJO Indu

    1/22/26 4:05:00 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Clorox Declares Regular Quarterly Dividend of $1.24 Per Share

    OAKLAND, Calif., Nov. 18, 2025 /PRNewswire/ -- The Clorox Company (NYSE:CLX) announced today that its board of directors has declared a quarterly dividend of $1.24 per share on the company's common stock. The dividend is payable Feb. 13, 2026, to shareholders of record as of the close of business on Jan. 28, 2026. Clorox has a long history of providing value to its shareholders through regular dividend payments and annual dividend increases. About The Clorox Company The Clorox Company (NYSE:CLX) champions people to be well and thrive every single day. Its trusted brands include Brita®, Burt's Bees®, Clorox®, Fresh Step®, Glad®, Hidden Valley®, Kingsford®, Liquid-Plumr® and Pine-Sol® as well

    11/18/25 6:20:00 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    $CLX
    Leadership Updates

    Live Leadership Updates

    View All

    Clorox Announces Appointment of Julia Denman and Stephanie Plaines to its Board of Directors

    OAKLAND, Calif., May 18, 2022 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today announced the appointment of Julia (Charter) Denman and Stephanie Plaines to its board of directors, bringing additional deep financial expertise and industry leadership experience. Denman, 51, brings nearly 30 years of leadership and financial experience in both the technology and consumer packaged goods sectors. As corporate vice president and head of internal audit, enterprise risk and compliance at Microsoft, she provides independent and objective assessments of the company's business strateg

    5/18/22 4:30:00 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    $CLX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Clorox Company (Amendment)

    SC 13G/A - CLOROX CO /DE/ (0000021076) (Subject)

    2/13/24 5:02:29 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    SEC Form SC 13G/A filed by Clorox Company (Amendment)

    SC 13G/A - CLOROX CO /DE/ (0000021076) (Subject)

    2/9/23 11:15:26 AM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    SEC Form SC 13G/A filed by Clorox Company (Amendment)

    SC 13G/A - CLOROX CO /DE/ (0000021076) (Subject)

    2/9/22 3:43:30 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary